15 Best Small-Cap Healthcare Stocks to Buy
The term small cap can be used to define established companies with a small market capitalization ranging anywhere between $300 million and $2 billion.
Posts Tagged ‘Cytokinetics Inc (CYTK)’
5 Best Small-Cap Healthcare Stocks to Buy
Below we presented the list of 5 Best Small-Cap Healthcare Stocks to Buy.
Top 10 Healthcare Stocks To Buy for the Future
Small- and mid-cap biotech and pharmaceutical companies represent some of the most compelling gambles available on the market.
Hedge Fund and Insider Trading News: Michael Platt, Warren Buffett, Balyasny Asset Management, AQR Capital, Aspen Group Inc (ASPU), W&T Offshore, Inc. (WTI), and More
BOSTON (Reuters) - Balyasny Asset Management, a Chicago-based hedge fund that shed $4 billion in assets last year and cut 20% of its staff, was back in positive territory for ...
13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)
Please follow Biotechnology Value Fund LP (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Biotechnology Value Fund LP or update...
13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)
You can access the original SEC filing by clicking here.
Here’s What You Should Know About The Finance World Today
"U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market.
New Changes in SAC Capital’s 13F Portfolio: Annies Inc (BNNY), Cytokinetics, Inc. (CYTK) And Other
In another round of filings with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have disclosed 4 new moves: reductions in the ownership...
Mark Lampert, Biotechnology Value Fund Up Stake In Cytokinetics, Inc. (CYTK), Reduce Exposure To Regado Biosciences Inc (RGDO)
Mark Lampert, the founder and manager of Biotechnology Value Fund, is bullish on Cytokinetics, Inc. (NASDAQ:CYTK).
Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)
At the moment, there are many indicators market participants can use to watch their holdings. Two of the most under-the-radar are hedge fund and insider trading activity.
This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)
Now, according to many investors, hedge funds are assumed to be overrated, outdated investment tools of an era lost to time.
Aegerion Pharmaceuticals, Inc. (AEGR): Cheers and Jeers for Amgen, Inc. (AMGN)’s Pipeline
Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc.
Cytokinetics, Inc. (CYTK), Amgen, Inc. (AMGN): Digging Deeper Into This Heart Failure Drug’s Miss
Before the market opened last Tuesday, Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc.
Astex Pharmaceuticals, Inc. (ASTX), GlaxoSmithKline plc (ADR) (GSK), Cytokinetics, Inc. (CYTK): Last Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
MiMedx Group Inc (MDXG), Cytokinetics, Inc. (CYTK), Amgen, Inc. (AMGN): A Trio of Horrendous Health-Care Stocks This Week
College football arrived in a big way over the past week or so, with plenty of big plays already.
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
In the eyes of many investors, hedge funds are viewed as overrated, old investment vehicles of an era lost to time.
What Hedge Funds Think About ArQule, Inc. (ARQL)
In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks.
Celgene Corporation (CELG), Cytokinetics, Inc. (CYTK), Astex Pharmaceuticals, Inc. (ASTX): Is the Biotech Bubble About to Burst?
"Bubble" can be a provocative word in investing circles. Think of all that comes to mind when you hear it -- perhaps other words like over-hyped, overvalued, risky, etc.
What’s a Smart Cytokinetics, Inc. (CYTK) Investor To Do?
In the eyes of many of your peers, hedge funds are seen as useless, old investment tools of a forgotten age.
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Companies to Watch Out For
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth.
Cytokinetics, Inc. (CYTK), Exelixis, Inc. (EXEL): Three Small Cap Biotech Stocks with Great Potential
Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S.
Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry.
OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?
To the average investor, there are many gauges shareholders can use to monitor stocks. Two of the most underrated are hedge fund and insider trading movement.
Cytokinetics, Inc. (CYTK): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds' portfolio at the end of March.
Hedge Funds Are Crazy About Cytokinetics, Inc. (CYTK)
Is Cytokinetics, Inc. (NASDAQ:CYTK) the right pick for your portfolio? Prominent investors are in a bullish mood.
Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?
BioDelivery Sciences International, Inc.
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood.
Amgen, Inc. (AMGN), Cytokinetics, Inc. (CYTK): A New Approach to Treating a Broken Heart
A failing heart is a lot like a glass Heinz Ketchup bottle. Squeezing the bottle isn't very efficient, so you smack that strategically placed '57,' and still no condiment. ...
Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident.
Zynga Inc (ZNGA), Cytokinetics, Inc. (CYTK), and More: 3 Stocks That Blew the Market Away
Every week, I take a look at three companies that beat market expectations, since I believe that it's the biggest factor in a stock beating the market.
